JPMorgan Chase & Co. Increases Vera Therapeutics (NASDAQ:VERA) Price Target to $65.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Biotechnology company Vera Therapeutics, Inc. (VERA) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to atacicept for the treatment of Immunoglobulin A Nephropathy or IgAN.
Vera Therapeutics, Inc. Presents 72-Week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) has received a consensus rating of “Buy” from the eight analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation, six have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The […]
New York State Common Retirement Fund increased its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Free Report) by 55.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,491 shares of the company’s stock after buying an additional 6,244 shares during the period. New York State Common Retirement Fund’s holdings in Vera […]